| For: | Androulakis I, Zavos C, Christopoulos P, Mastorakos G, Gazouli M. Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease. World J Gastroenterol 2015; 21(47): 13205-13211 [PMID: 26715803 DOI: 10.3748/wjg.v21.i47.13205] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i47/13205.htm |
| Number | Citing Articles |
| 1 |
Roger A. Levy, Guilherme R. de Jesús, Nilson R. de Jesús, Evandro M. Klumb. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmunity Reviews 2016; 15(10) doi: 10.1016/j.autrev.2016.07.014
|
| 2 |
Jiaxin Zhang, Yuge Zhao, Tianling Hou, Hairong Zeng, Dipika Kalambhe, Bing Wang, Xiaoyan Shen, Yongzhuo Huang. Macrophage-based nanotherapeutic strategies in ulcerative colitis. Journal of Controlled Release 2020; 320 doi: 10.1016/j.jconrel.2020.01.047
|
| 3 |
Dora Grgić, Silvija Čuković Čavka, Vesna Elveđi Gašparović, Nikša Turk, Marko Brinar, Zlatko Marušić, Željko Krznarić. Pregnancy-Onset Acute Severe Colitis after in vitro Fertilization Embryo Transfer. Case Reports in Gastroenterology 2020; 14(3) doi: 10.1159/000509502
|
| 4 |
Powell Perng, John G. Zampella, Ginette A. Okoye. Management of hidradenitis suppurativa in pregnancy. Journal of the American Academy of Dermatology 2017; 76(5) doi: 10.1016/j.jaad.2016.10.032
|
| 5 |
Tamara Lund, Simon Francis Thomsen. Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series. Dermatologic Therapy 2017; 30(3) doi: 10.1111/dth.12454
|
| 6 |
Angela Lo, Brittany Thompson, Naveed Sami. Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review. American Journal of Clinical Dermatology 2024; 25(2) doi: 10.1007/s40257-023-00830-3
|
| 7 |
Emily Nesbitt, Stephanie Clements, Marcia Driscoll. A concise clinician’s guide to therapy for hidradenitis suppurativa. International Journal of Women's Dermatology 2020; 6(2) doi: 10.1016/j.ijwd.2019.11.004
|
| 8 |
Elisa Molinelli, Claudia Sapigni, Anna Campanati, Valerio Brisigotti, Annamaria Offidani. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opinion on Drug Metabolism & Toxicology 2020; 16(11) doi: 10.1080/17425255.2020.1810233
|
| 9 |
Christopher J. Sayed, Jennifer L. Hsiao, Martin M. Okun. Clinical Epidemiology and Management of Hidradenitis Suppurativa. Obstetrics & Gynecology 2021; 137(4) doi: 10.1097/AOG.0000000000004321
|
| 10 |
Madeline Ngo, Hannah R. Chang, Elysha K. Rose, Melissa M. Mauskar. Pregnancy Dermatoses for the Inpatient Dermatologist. Current Dermatology Reports 2024; 13(4) doi: 10.1007/s13671-024-00451-x
|
| 11 |
Marco Galluzzo, Simone D’Adamio, Luca Bianchi, Marina Talamonti. Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab. Journal of Dermatological Treatment 2019; 30(1) doi: 10.1080/09546634.2018.1468066
|
| 12 |
Omotayo Segun-Omosehin, Natalie E. Bourdakos, Kosta G. Tzanis, Marie Michele Macaron, Fares Jamal, Lisa Marks, Abdullah Hamad, Talha A. Malik. Pairwise Comparative Safety and Effectiveness of Anti-TNF Blockers, Vedolizumab, and Ustekinumab During Pregnancy: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2026; doi: 10.1007/s10620-026-09948-w
|
| 13 |
Sung-Ae Jung. Concerns in pregnancy and childbirth of women with inflammatory bowel disease. Intestinal Research 2016; 14(2) doi: 10.5217/ir.2016.14.2.107
|
| 14 |
Alexandra P. Charrow, Robert G. Micheletti. A Comprehensive Guide to Hidradenitis Suppurativa. 2022; doi: 10.1016/B978-0-323-77724-7.00018-8
|
| 15 |
Michael W. Winter, Joel V. Weinstock. The Autoimmune Diseases. 2020; doi: 10.1016/B978-0-12-812102-3.00046-4
|
| 16 |
Gary R. Lichtenstein, Brian G. Feagan, Uma Mahadevan, Bruce A. Salzberg, Wayne Langholff, James G. Morgan, Michael Safdi, Riikka Nissinen, François Taillard, William J. Sandborn, Russell D. Cohen. Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report. American Journal of Gastroenterology 2018; 113(11) doi: 10.1038/s41395-018-0202-9
|
| 17 |
Mathurin Flamant, Stephane Paul, Xavier Roblin. Golimumab for the treatment of ulcerative colitis. Expert Opinion on Biological Therapy 2017; 17(7) doi: 10.1080/14712598.2017.1327576
|
| 18 |
Ursula Wiedermann, Harald H. Sitte, Heinz Burgmann, Alexander Eser, Petra Falb, Heidemarie Holzmann, Maria Kitchen, Marcus Köller, Herwig Kollaritsch, Michael Kundi, Hans Lassmann, Ingomar Mutz, Winfried F. Pickl, Elisabeth Riedl, Maria Sibilia, Florian Thalhammer, Barbara Tucek, Werner Zenz, Karl Zwiauer. Impfungen bei Immundefekten/Immunsuppression – Expertenstatement und Empfehlungen. Wiener klinische Wochenschrift 2016; 128(S4) doi: 10.1007/s00508-016-1033-6
|
| 19 |
Jing Shi, Dong-Lin Han, Han Jiang, Yi-Meng Ge, Qiong Liu, Jun Zhang, Xiao-Nan Zhang, Jie Zhao. Oncofertility pharmacovigilance in women receiving immune checkpoint inhibitors: Reproductive risks, fertility preservation, and pregnancy outcomes. Journal of Reproductive Immunology 2026; 175 doi: 10.1016/j.jri.2026.104894
|
| 20 |
Murali Krishna Moka, Deepalaxmi Rathakrishnan, Sriram. D.K, Melvin George. How safe are the TNF alpha inhibitors with respect to pregnancy outcomes in autoimmune diseases?. Reproductive Toxicology 2026; 141 doi: 10.1016/j.reprotox.2026.109202
|